Von Willebrand factor is a multifaceted player in hemostasis requiring a diverse array of analytical and diagnostic approaches
Open Access
- 9 July 2025
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 18 (9) , 701-718
Abstract
Von Willebrandfactor (VWF) plays a crucial role in hemostasis: its interactions with endothelialmatrices, platelets, and factor VIII make it a key player in both primaryhemostasis and coagulation. Pathology associated with VWF spans mild to severebleeding manifestations in the case of inherited von Willebrand disease (VWD),the most common congenital bleeding disorder, or acquired von Willebrandsyndrome (AVWS). Conversely, VWF can be associated with thromboticmanifestations in situations related to inflammation, infection, or inheritedor acquired ADAMTS13 defects. This reviewarticle aims to provide guidance on the use and interpretation of clinicallaboratory assays available to measure VWF and other factors related to VWD.Different VWF tests can be used in different clinical settings for efficientdiagnosis and patient management. Assay limitations are also addressed. A myriad oflaboratory assays, from first line to esoteric assays, exist to enable adequatediagnosis of VWD and other diseases influenced by VWF. Clinical investigationsof VWF are complicated because VWF has multiple functions which variably dependon the patient's pathophysiological status. The right choice of assays istherefore critical to provide adequate diagnosis in due time and withreasonable analytical efforts.Keywords
This publication has 101 references indexed in Scilit:
- Laboratory diagnosis of von Willebrand disease: the phenotype2024
- Clinical Evaluation and Management of Thrombotic MicroangiopathyArthritis & Rheumatology, 2023
- Biomarkers of endothelial dysfunction are associated with poor outcome in COVID‐19 patients: A systematic review and meta‐analysisReviews in Medical Virology, 2023
- Is ≥ 100% the magic number to rule out the laboratory diagnosis of von Willebrand disease based on initial testing?American Journal of Hematology, 2021
- Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand diseaseResearch and Practice in Thrombosis and Haemostasis, 2021
- Acquired von Willebrand syndrome in monoclonal gammopathy – A scoping review on hemostatic managementResearch and Practice in Thrombosis and Haemostasis, 2021
- Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distributionResearch and Practice in Thrombosis and Haemostasis, 2020
- Laboratory misdiagnosis of von Willebrand disease in post‐menarchal females: A multi‐center studyAmerican Journal of Hematology, 2020
- Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19Intensive Care Medicine, 2020
- Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white populationBlood Cells, Molecules, and Diseases, 2017